Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug Dosing: Obese Patients

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...

Obesity

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...

Diabetes: Management and Pharmacotherapy

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

Secondary Healthcare System

Secondary Healthcare System

Secondary healthcare is offered by a specialist, generally in hospitals or clinics for patients referred by primary healthcare providers. It occurs when a person has an illness or injury that requires specific medical care. Secondary care is often referred to as acute care. Secondary care can range from uncomplicated care to repair a minor laceration or treat a strep throat infection to more complicated emergent care, such as treating a head injury sustained in an automobile accident. Whatever...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Optimising the Delphi survey method during core set development: The impact of summarised feedback on stakeholders' prioritisation of core data items and consensus.

PloS one·2026

Same author

Global Variations in Practices after Bariatric and Metabolic Surgery; the PARTNER Study.

Obesity surgery·2025

Same author

Disparities in Complication Rates Among Ethnic Minorities Undergoing Bariatric Surgery in the UK.

Obesity surgery·2025

Same author

Reversal of Roux-en-Y Gastric Bypass: A Multi-Centric Analysis of Indications, Techniques, and Surgical Outcomes.

Obesity surgery·2025

Same author

An international Delphi consensus on patient preparation for metabolic and bariatric surgery.

Clinical obesity·2024

Same author

A Core set of patient-reported outcome measures to measure quality of life in obesity treatment research.

Obesity reviews : an official journal of the International Association for the Study of Obesity·2024

Search research articles

Related Experiment Video

Updated: Mar 18, 2026

Multidisciplinary Approach to Obesity Management: A Case Report

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

Obesity Treatment in the UK Health System.

Matthew S Capehorn¹, David W Haslam², Richard Welbourn³

¹Rotherham Institute for Obesity (RIO), Rotherham, S65 1DA, UK.

Current Obesity Reports

|June 29, 2016

Summary

Obesity rates are rising globally, impacting public health significantly. Despite a structured 4-tier care model in the UK, fragmented responsibility and inconsistent service provision hinder effective obesity management.

Keywords:

Clinical commissioning group Commissioning Multidisciplinary team National Health Service Obesity Tier 3 Tier 4 health Tier model

More Related Videos

An Acupoint Catgut-embedding Therapy for Treating Obesity

An Acupoint Catgut-embedding Therapy for Treating Obesity

Published on: April 4, 2025

Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice

Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice

Published on: March 20, 2017

Related Experiment Videos

Last Updated: Mar 18, 2026

Multidisciplinary Approach to Obesity Management: A Case Report

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

An Acupoint Catgut-embedding Therapy for Treating Obesity

An Acupoint Catgut-embedding Therapy for Treating Obesity

Published on: April 4, 2025

Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice

Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice

Published on: March 20, 2017

Area of Science:

Public Health
Health Policy
Obesity Research

Background:

Rising global obesity rates pose a significant public health challenge, second only to smoking.
Obesity is strongly linked to physical inactivity, highlighting the need for integrated health strategies.
The UK National Health Service (NHS) underwent significant restructuring following the 2012 Health and Social Care Act.

Purpose of the Study:

To examine the current landscape of obesity treatment commissioning in the UK.
To analyze the implementation and effectiveness of the 4-tier model of care for obesity.
To identify challenges in stakeholder responsibility and service provision for obesity management.

Main Methods:

Policy analysis of NHS England and Department of Health guidelines.
Review of the 4-tier model for obesity treatment commissioning.
Assessment of service provision and stakeholder roles in UK obesity care.

Main Results:

A 4-tier care model (primary activity, community, specialist, bariatric surgery) is established for obesity treatment.
Despite clear guidelines, no single stakeholder assumes overall responsibility for obesity care.
Inconsistent service provision, a 'postcode lottery', and limited political will to address the obesogenic environment persist.

Conclusions:

The current UK obesity care system suffers from fragmented responsibility and inequitable service access.
Addressing the obesogenic environment and clarifying stakeholder accountability are crucial for improving obesity management.
Further political will and strategic planning are needed to ensure comprehensive and equitable obesity care across the UK.